LaGray is the first fully-integrated generic pharmaceutical manufacturer in West Africa. We produce both active pharmaceutical ingredients and finished dosage forms.

Our focus is on drugs for treating endemic diseases such as HIV-AIDS, opportunistic infections, malaria, tuberculosis and parasitic, bacterial and fungal infections. The high burden of disease in sub-Saharan Africa contributes to >70% of the mortality in the region and account for massive economic losses.

Although there are currently effective drugs for treating most of these diseases, the issue is affordability and availability..